KETINK 100 mg/ml Solution for Injection Португалия - английский - HMA (Heads of Medicines Agencies)

ketink 100 mg/ml solution for injection

industrial veterinaria s.a. - ketoprofen 100 mg/ml - solution for injection - cattle food, horses food, pigs food - ketoprofen

KETINK 100 mg/ml Solution for Injection Румыния - английский - HMA (Heads of Medicines Agencies)

ketink 100 mg/ml solution for injection

industrial veterinaria s.a. - ketoprofen 100 mg/ml - solution for injection - cattle food, horses food, pigs food - ketoprofen

KETINK 100 mg/ml Solution for Injection Словения - английский - HMA (Heads of Medicines Agencies)

ketink 100 mg/ml solution for injection

industrial veterinaria s.a. - ketoprofen 100 mg/ml - solution for injection - cattle food, horses food, pigs food - ketoprofen

KETINK 100 mg/ml Solution for Injection Великобритания - английский - HMA (Heads of Medicines Agencies)

ketink 100 mg/ml solution for injection

industrial veterinaria s.a. - ketoprofen 100 mg/ml - solution for injection - cattle food, horses food, pigs food - ketoprofen

Nobilis IB 4-91 Европейский союз - английский - EMA (European Medicines Agency)

nobilis ib 4-91

intervet international bv - live attenuated avian infectious bronchitis virus variant strain 4-91 - immunologicals for aves - chicken - active immunisation of chickens to reduce the respiratory signs of infectious bronchitis caused by the variant strain ib 4-91.

Adempas Европейский союз - английский - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.